These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17135364)

  • 1. Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning.
    Hägerkvist R; Sandler S; Mokhtari D; Welsh N
    FASEB J; 2007 Feb; 21(2):618-28. PubMed ID: 17135364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro.
    Hägerkvist R; Makeeva N; Elliman S; Welsh N
    Cell Biol Int; 2006 Dec; 30(12):1013-7. PubMed ID: 17020808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
    Rakshit S; Bagchi J; Mandal L; Paul K; Ganguly D; Bhattacharjee S; Ghosh M; Biswas N; Chaudhuri U; Bandyopadhyay S
    Apoptosis; 2009 Mar; 14(3):298-308. PubMed ID: 19153832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the small tyrosine kinase inhibitor Imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?
    Welsh N
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1743-50. PubMed ID: 22998750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-induced human islet cell death in vitro correlates with a persistently high phosphorylation of STAT-1, but not with NF-κB activation.
    Hindlycke H; Lu T; Welsh N
    Biochem Biophys Res Commun; 2012 Feb; 418(4):845-50. PubMed ID: 22326919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
    Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
    Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
    Manna P; Sinha M; Sil PC
    Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.
    Eldor R; Yeffet A; Baum K; Doviner V; Amar D; Ben-Neriah Y; Christofori G; Peled A; Carel JC; Boitard C; Klein T; Serup P; Eizirik DL; Melloul D
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5072-7. PubMed ID: 16551748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by interleukin (IL)-1beta.
    Papaccio G; Graziano A; D'Aquino R; Valiante S; Naro F
    J Cell Physiol; 2005 Jul; 204(1):124-30. PubMed ID: 15622524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.
    Stephens LA; Thomas HE; Kay TW
    J Autoimmun; 1997 Jun; 10(3):293-8. PubMed ID: 9218757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
    Li X; Chen H; Epstein PN
    Diabetes; 2006 Jun; 55(6):1592-604. PubMed ID: 16731821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice.
    Knight B; Tirnitz-Parker JE; Olynyk JK
    Gastroenterology; 2008 Sep; 135(3):969-79, 979.e1. PubMed ID: 18602920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
    Juurikivi A; Sandler C; Lindstedt KA; Kovanen PT; Juutilainen T; Leskinen MJ; Mäki T; Eklund KK
    Ann Rheum Dis; 2005 Aug; 64(8):1126-31. PubMed ID: 16014680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib mesylate stimulates low-density lipoprotein receptor-related protein 1-mediated ERK phosphorylation in insulin-producing cells.
    Fred RG; Boddeti SK; Lundberg M; Welsh N
    Clin Sci (Lond); 2015 Jan; 128(1):17-28. PubMed ID: 24865476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death effectors of beta-cell apoptosis in type 1 diabetes.
    Lee MS; Chang I; Kim S
    Mol Genet Metab; 2004; 83(1-2):82-92. PubMed ID: 15464423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta.
    Kurosu T; Tsuji K; Kida A; Koyama T; Yamamoto M; Miura O
    Oncogene; 2007 May; 26(21):2975-87. PubMed ID: 17130834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.